Full throttle for these 3 stocks as uptrends break new ground

Published: November 25 2022, 13:20 GMT+0

Full throttle for these 3 stocks as uptrends break new ground

GoHealth, Inc., MICT, Inc., Mirati Therapeutics, Inc. are the ones to notice as they lead stocks on an uptrend.

Markets closed higher Wednesday, as Nasdaq gained 0.99% and closed at 11,300. S&P 500 closed the day at 4,027.26, having gained 0.59%.

What is an uptrend?

A trend is the overall direction of a market or an asset's trading price over a certain period. An uptrend is when the price is generally pointing upwards; there can be certain periods of time when the price falls, yet the trend remains in an upward direction.

At $9.03, GoHealth continues its uptrend: GoHealth ended Wednesday at $9.03, a 2.03% increase

GoHealth lived up to expectations Wednesday by maintaining its set course — generally flat but with a slight bullish bias, GoHealth, Inc. ranged between $8.77 and $9.39 before closing higher at $9.03. GoHealth continues an 8 day uptrend, gaining a total of 2,270%. The day's trading volume totalled 130,803 shares — below the 21-day average of 1.33 million.

The company has a market cap of $80.28 million with an average daily volume of 1.33 million shares. Having set a significant high of $9.03 a month ago, the Medicare plan marketplace is trading 2,590% lower. $133 million was GoHealth's last reported revenue with -22 cents being the current EPS.

An increase of 86.15% in 15 days: Micronet Enertec Technologies levels up 15.24% in Wednesday's session; traders eye opening bell in a hour time

MICT is on a 15 day bullish run gaining 40 cents (86.15%). it was more of the same for Micronet Enertec Technologies Wednesday — after ending Tuesday's session at $1.05, MICT went up to $1.22 Wednesday only to fall back and close at $1.21. Daily trading volume (1.30 million shares) increased, making up 430% of the 21-day average (301,440).

A 61.26% increase in 12 days: Wednesday Mirati Therapeutics increased by 11.31%, ended the session at $95.85

Mirati Therapeutics displays further gains following a recent trend of 12 days and $26.67. Wednesday's session pointed in the same direction — bullish sentiment helped the biotechnology developer to hammer out a noteworthy $86.38 to $95.95 range Wednesday, and finally closing at $95.85 to end the session. Daily trading volume (2.83 million shares) increased, making up 213% of the 21-day average (1.33 million).